PUBLISHER: The Business Research Company | PRODUCT CODE: 1957565
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957565
Over-the-counter (OTC) artificial tears are non-prescription eye drops designed to lubricate and relieve dryness, irritation, or discomfort in the eyes caused by environmental factors, digital screen use, or medical conditions such as dry eye syndrome. They provide quick and accessible relief and are widely used for routine eye hydration without the need for a doctor's prescription.
The main types of OTC artificial tears include cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, and polyethylene glycol-based tears. Cellulose-derived tears are formulated with cellulose-based polymers to mimic natural tears, offering long-lasting moisture and lubrication for dry or irritated eyes. These products are available in multiple container types, including plastic single-dose and multi-dose containers, and come in preservative-based or preservative-free formulations. They are used in applications such as dry eye syndrome, allergies, infections, ultraviolet (UV) and blue light protection, and contact lens moisture retention. Key distribution channels include hospital pharmacies, retail and drugstore pharmacies, and online pharmacies.
Tariffs have influenced the OTC artificial tears market by increasing the cost of imported raw materials such as glycerin, cellulose derivatives, and polyethylene glycol. Segments like oil-based emulsion tears and polyethylene glycol formulations are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased product prices and supply chain adjustments. However, tariffs have also encouraged local manufacturing, innovation in alternative formulations, and investment in domestic production capacities, creating opportunities for regional players.
The over-the-counter (otc) artificial tears market research report is one of a series of new reports from The Business Research Company that provides over-the-counter (otc) artificial tears market statistics, including over-the-counter (otc) artificial tears industry global market size, regional shares, competitors with a over-the-counter (otc) artificial tears market share, detailed over-the-counter (otc) artificial tears market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (otc) artificial tears industry. This over-the-counter (otc) artificial tears market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The over-the-counter (otc) artificial tears market size has grown strongly in recent years. It will grow from $4.94 billion in 2025 to $5.24 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to limited availability of non-prescription eye drops, growing awareness of eye health, increasing screen time among adults and children, reliance on conventional cellulose-based tears, expansion of hospital and retail pharmacy networks.
The over-the-counter (otc) artificial tears market size is expected to see strong growth in the next few years. It will grow to $6.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to development of glycerin and oil-based emulsion tears, rising adoption of polyethylene glycol formulations, increasing demand for contact lens moisture retention products, growth of online pharmacy channels, innovations in preservative-free and multi-dose packaging. Major trends in the forecast period include rising incidence of dry eye syndrome due to digital screen usage, increased demand for preservative-free formulations, growing preference for multi-dose and single-dose containers, expansion of online pharmacies and e-commerce distribution, awareness about uv and blue light protection for eye health.
The increasing prevalence of eye disease is expected to drive growth in the over-the-counter (OTC) artificial tears market in the coming years. Eye diseases are conditions that impair the normal function or structure of the eye, potentially leading to vision problems or loss if untreated. The rising prevalence of eye disease is largely due to aging populations, who are more susceptible to vision impairments, creating greater demand for effective eye care solutions. OTC artificial tears help manage eye disease by providing soothing lubrication that relieves dryness, reduces irritation, and protects the ocular surface, improving overall eye comfort. For example, in August 2023, the World Health Organization, a Switzerland-based international public health organization, reported that more than 2.2 billion people worldwide were living with near or distance vision impairment, with the majority of cases occurring in adults over 50. Therefore, the increasing prevalence of eye disease is driving the OTC artificial tears market.
Key companies in the OTC artificial tears market are focusing on advanced preservative-free formulations, such as lipid layer stabilization formulas, to provide long-lasting and effective relief. Lipid layer stabilization strengthens the outer oily layer of the tear film to prevent rapid evaporation and maintain eye moisture. For instance, in February 2025, Alcon Inc., a Switzerland-based eye care company, launched SYSTANE PRO Preservative-Free (PF), an OTC artificial tear featuring a triple-action formula to hydrate, restore, and protect dry eyes. Its multi-dose, preservative-free design combines hyaluronate, nano-sized lipids, and HP-Guar to provide deep hydration, restore tear film stability, and protect the ocular surface, delivering lasting relief even with frequent use.
In July 2023, Bausch + Lomb Corporation, a Canada-based eye health company, acquired the Blink OTC eye drop product line from Johnson & Johnson Vision for $106.5 million. This acquisition strengthens Bausch + Lomb's OTC eye care portfolio by adding the Blink line of artificial tears and rewetting drops, expanding consumer access to trusted solutions for dry eye and contact lens discomfort. Johnson & Johnson Vision, a U.S.-based eye health solutions company, manufactures OTC artificial tears to provide relief from dry eye and contact lens-related discomfort.
Major companies operating in the over-the-counter (otc) artificial tears market are AbbVie Inc., Abbott Laboratories Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Limited, URSAPHARM Arzneimittel GmbH, OCuSOFT Inc., Laboratoires Thea S.A.S., I-MED Pharma Inc.
North America was the largest region in the over-the-counter (OTC) artificial tears market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the over-the-counter (otc) artificial tears market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the over-the-counter (otc) artificial tears market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The over-the-counter (OTC) artificial tears market consists of sales of hyaluronic acid-based tears, electrolyte-based tears, vitamin-enriched tears, medium viscosity tears, and high viscosity tears. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Over-The-Counter (OTC) Artificial Tears Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses over-the-counter (otc) artificial tears market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for over-the-counter (otc) artificial tears ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The over-the-counter (otc) artificial tears market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.